TXN TEXAS INSTRUMENTS INC
Semiconductors & Related Devices · Nasdaq · SEC CIK 97476 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY20.3%
TTM net income YoY41.0%
TTM EPS YoY40.4%
Revenue 3-yr CAGR4.7%
Net income 3-yr CAGR0.1%
Margins
Gross margin60.2%
Operating margin40.8%
Net margin34.3%
FCF margin35.2%
EBITDA margin51.3%
Returns
ROE39.7%
ROA19.8%
ROIC (approx.)26.5%
Asset turnover0.58x
Leverage & solvency
Liabilities / assets47.9%
Debt / equity0.71x
Current ratio5.59x
Interest coverage15.01x
Cash quality & payout
Operating cash flow / net income1.39x
Accruals ratio-7.7%
Payout ratio72.7%
Capex / revenue12.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $6.05B | $5.46B | $4.83B | $4.42B | $4.74B | $4.45B | $4.07B | $4.01B |
| Cost of revenue | $2.17B | $2.11B | $2.03B | $1.95B | $2.02B | $1.87B | $1.76B | $1.69B |
| Gross profit | $3.89B | $3.35B | $2.80B | $2.47B | $2.72B | $2.58B | $2.31B | $2.31B |
| R&D expense | $530.00M | $535.00M | $510.00M | $521.00M | $518.00M | $527.00M | $517.00M | $491.00M |
| SG&A expense | $476.00M | $490.00M | $464.00M | $446.00M | $457.00M | $485.00M | $472.00M | $446.00M |
| Operating income | $2.87B | $2.31B | $1.81B | $1.47B | $1.66B | $1.56B | $1.32B | $1.38B |
| Interest expense | $141.00M | $141.00M | $141.00M | $141.00M | $141.00M | $133.00M | $128.00M | $130.00M |
| Pretax income | $2.81B | $2.24B | $1.71B | $1.37B | $1.58B | $1.48B | $1.28B | $1.36B |
| Income tax | $380.00M | $258.00M | $169.00M | $209.00M | $220.00M | $183.00M | $97.00M | $154.00M |
| Net income | $2.42B | $1.98B | $1.54B | $1.16B | $1.36B | $1.29B | $1.18B | $1.21B |
| EBITDA | $3.43B | $2.86B | $2.35B | $2.01B | $2.16B | $2.02B | $1.75B | $1.79B |
| EPS (basic) | 2.64 | 2.16 | 1.69 | — | 1.49 | 1.42 | 1.29 | — |
| EPS (diluted) | 2.62 | 2.14 | 1.68 | — | 1.48 | 1.41 | 1.28 | — |
| Dividends declared per share | 1.42 | 1.42 | 1.42 | 1.42 | 1.36 | 1.36 | 1.36 | 1.36 |
| Weighted avg. shares (diluted) | 921.00M | 920.00M | 914.00M | — | 914.00M | 912.00M | 916.00M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $4.21B | $3.66B | $3.55B | $3.23B | $3.31B | $3.04B | $2.76B | $3.20B |
| Short-term investments | $3.93B | $3.34B | $1.55B | $1.66B | $1.88B | $2.31B | $2.24B | $4.38B |
| Receivables | $2.62B | $2.52B | $2.25B | $1.96B | $2.06B | $1.93B | $1.86B | $1.72B |
| Inventory | $4.67B | $4.61B | $4.70B | $4.80B | $4.83B | $4.81B | $4.69B | $4.53B |
| Current assets | $16.88B | $15.76B | $13.80B | $13.75B | $13.88B | $14.48B | $13.09B | $15.03B |
| PP&E, net | $11.83B | $11.91B | $12.14B | $12.32B | $12.35B | $12.32B | $11.81B | $11.35B |
| Goodwill | $4.33B | $4.33B | $4.33B | $4.33B | $4.36B | $4.36B | $4.36B | $4.36B |
| Intangibles | $301.00M | $314.00M | — | $238.00M | — | — | — | — |
| Total assets | $36.84B | $35.88B | $34.39B | $34.59B | $35.00B | $34.93B | $33.76B | $35.51B |
| Current liabilities | $3.02B | $3.24B | $3.10B | $3.16B | $3.12B | $2.49B | $2.49B | $3.64B |
| Short-term debt | $650.00M | $1.15B | $1.15B | $500.00M | $500.00M | $0 | $0 | $750.00M |
| Long-term debt | $12.90B | $12.90B | $12.90B | $13.55B | $13.55B | $14.04B | $12.85B | $12.85B |
| Total debt | $13.55B | $14.05B | $14.05B | $14.05B | $14.05B | $14.04B | $12.85B | $13.60B |
| Total liabilities | $17.65B | $17.88B | $17.61B | $18.31B | $18.38B | $18.53B | $17.35B | $18.61B |
| Shareholders' equity | $19.18B | $18.01B | $16.78B | $16.27B | $16.63B | $16.40B | $16.41B | $16.90B |
| Net debt | $9.34B | $10.39B | $10.50B | $10.82B | $10.73B | $11.00B | $10.09B | $10.40B |
| Cash flow statement | ||||||||
| Operating cash flow | $3.42B | $2.70B | $1.52B | $2.25B | $2.19B | $1.86B | $849.00M | $2.00B |
| Capital expenditure | $463.00M | $514.00M | $676.00M | $925.00M | $1.20B | $1.30B | $1.12B | $1.19B |
| Free cash flow | $2.96B | $2.19B | $844.00M | $1.33B | $993.00M | $555.00M | -$274.00M | $806.00M |
| Investing cash flow | -$987.00M | -$1.70B | -$47.00M | -$676.00M | -$681.00M | -$1.33B | $1.25B | $614.00M |
| Financing cash flow | -$1.88B | -$890.00M | -$1.15B | -$1.66B | -$1.24B | -$244.00M | -$2.54B | -$2.00B |
| Depreciation & amortization | $555.00M | $547.00M | $541.00M | $537.00M | $497.00M | $460.00M | $424.00M | $416.00M |
| Stock-based compensation | $95.00M | $127.00M | $109.00M | $81.00M | $93.00M | $129.00M | $116.00M | $78.00M |
| Dividends paid | $1.30B | $1.29B | $1.29B | $1.29B | $1.24B | $1.24B | $1.24B | $1.24B |
| Share buybacks | $48.00M | $27.00M | $158.00M | $403.00M | $119.00M | $302.00M | $653.00M | $537.00M |
Free plan shows the latest 8 periods; Pro shows all 74 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.